Flashpoint Therapeutics

Flashpoint Therapeutics

Pre-clinical
Cambridge, United StatesFounded 2021flashpoint.bio

Flashpoint is developing nanotherapeutic candidates that can co-deliver precise RNA, DNA and peptide payloads to the right cells at the right time.

Founded
2021
Focus
RNA & Gene Therapy

About

Flashpoint is developing nanotherapeutic candidates that can co-deliver precise RNA, DNA and peptide payloads to the right cells at the right time.

Funding History

1

Total raised: $10M

Seed$10MUndisclosedMay 15, 2023

Company Info

TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile